Sunday 11 October 2026
Export all RLYB data to Excel Powerpack
Rallybio Corporation
RLYB Healthcare Biotechnology
In the quarter to June 2026, revenue was flat, EPS grew 535.2% and free cash flow grew 648.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
17.02
0.03
+0.18%
Follow RLYB
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | — | — | — | — | — | — |
P/S ratio |
36.02 | 0.00 | — | — | — | — | — | — |
Altman Z-Score |
(3.12) | (3.97) | — | — | — | — | — | — |
P/FCF ratio |
0.00 | 0.00 | — | — | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
0.76 | (4.03) | — | — | — | — | — | — |
P/Operating CF |
(6.61) | (4.24) | — | — | — | — | — | — |
P/B ratio |
0.53 | 0.68 | — | — | — | — | — | — |
Price to Tangible BV |
0.53 | 0.68 | — | — | — | — | — | — |
EV/Sales |
(27.77) | 0.00 | — | — | — | — | — | — |
EV/EBITDA |
0.71 | 0.38 | — | — | — | — | — | — |
EV/Operating CF |
0.80 | 0.48 | — | — | — | — | — | — |
EV/FCF |
0.80 | 0.48 | — | — | — | — | — | — |
Quick Ratio |
12.96 | 10.50 | 11.87 | 15.73 | 26.76 | 24.00 | 5.11 | — |
Current Ratio |
14.50 | 10.87 | 12.39 | 16.71 | 27.61 | 24.18 | 5.50 | — |
Net Debt/EBITDA |
1.63 | 1.06 | 1.34 | 2.48 | 3.85 | 5.56 | 1.10 | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
3.32 | 0.85 | 0.81 | 0.86 | 0.97 | 0.83 | 0.86 | — |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.20 | (3.05) | (2.21) | 0.00 | — |
Interest Coverage |
— | — | — | (34.58) | (4,564.80) | (516.39) | (149.51) | — |
| (15.01%) | (68.85%) | (54.13%) | (38.65%) | (30.17%) | (45.71%) | 0.00% | — | |
| (13.77%) | (62.89%) | (50.37%) | (36.76%) | (29.02%) | (32.36%) | (162.57%) | — | |
ROIC |
(641.77%) | 0.00% | 0.00% | (13,135.45%) | (10,645.52%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
(15.74%) | (93.62%) | (70.50%) | (39.41%) | (26.89%) | (19.49%) | (101.44%) | — |
Average Days of Receivables |
0.00 | 0.00 | — | — | — | — | — | — |
Research and Development Expense of Revenue |
2,284.03% | 6,526.26% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
1,669.58% | 3,085.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
619.35% | 1,256.76% | 0.00% | 0.00% | 0.00% | 0.00% | — | — |
Graham Net Nets |
1.84 | 1.47 | — | — | — | — | — | — |
Graham Number |
0.00 | 0.00 | — | — | — | — | — | — |
Earnings Yield |
(28.80%) | (140.63%) | — | — | — | — | — | — |
Free Cash Flow Yield |
(96.55%) | (117.96%) | — | — | — | — | — | — |
Revenue per Share |
0.15 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
(5.30) | (9.05) | (11.92) | (14.40) | (14.27) | (10.14) | (0.47) | — |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | (0.10) | (0.06) | 0.00 | — |
Free Cash Flow per Share |
(5.30) | (9.05) | (11.92) | (14.42) | (14.38) | (10.20) | (0.47) | — |
Cash per Share |
9.72 | 12.04 | 21.74 | 42.49 | 54.97 | 64.52 | 0.61 | — |
Shareholders Equity per Share |
10.29 | 11.33 | 21.00 | 42.57 | 55.05 | 62.57 | 0.52 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
10.29 | 11.33 | 21.00 | 42.57 | 55.05 | 62.57 | 0.52 | — |
Free Cash Flow |
(29.81) | (49.28) | (60.28) | (57.34) | (45.87) | (22.18) | (15.03) | — |
Working Capital |
57.03 | 61.60 | 105.53 | 168.75 | 174.32 | 135.42 | 17.11 | — |
Capital Expenditures |
— | — | (0.01) | (0.05) | (0.33) | (0.14) | (0.19) | — |
Net Current Asset Value |
56.95 | 61.39 | 105.35 | 168.38 | 174.29 | 135.41 | 16.17 | — |
EV/EBIT |
0.72 | 0.39 | — | — | — | — | — | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Price to Operating Income |
0.00 | 0.00 | — | — | — | — | — | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
(20.91) | (12.88) | (11.95) | (0.70) | 0.21 | 0.22 | 0.13 | — |
Cash ROIC |
(26.46%) | (38.75%) | (27.89%) | (16.95%) | (13.07%) | (8.03%) | (41.37%) | — |
Accounts Receivable Turnover |
0.00 | 0.00 | — | — | — | — | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11,893.73 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Payables |
0.20 | 0.63 | 1.05 | 0.86 | 1.09 | 1.22 | — | — |
Average Assets |
65.18 | 91.86 | 148.03 | 181.31 | 162.02 | 81.73 | 10.80 | — |
Average Common Equity |
59.81 | 83.92 | 137.75 | 172.46 | 155.80 | 57.86 | — | — |
Columns are period end dates